Algunas Referencias

1. Selman M, Chapela R, Montaño M, Soto R, Díaz de León. Cambios en el contenido de colágena en diferentes enfermedades fibrosantes del pulmón. Archivos de Investigación Medica 1982; 13 ( 08): 93-100 2. Selman M, Montaño M, Ramos C, Chapela R. Concentration biosynthesis and degradation of collagenase in idiopathic pulmonary fibrosis. Thorax 1986; 41: 355-359 3. Selman M, Montaño M, Ramos C, Chapela R, González G, Vadillo F. Lung collagen metabolism and the clinical course of the hypersensitivity. Chest 1988; 94 ( 2 ): 347-3353

4. Montaño M, Ramos C, González G, Vadillo F, Pardo A, Selman M. Lung collagenase inhibitors and spontaneous and latent collagenase activity in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. Chest 1989; 96 (5): 1115-1119

5. Pardo A, Selman M, Ramirez R, Ramos C, Montaño M, Stricklin G, Raghu G. Production collagenase and tissue inhibitors of metalloproteinases by fibroblast derived from normal and fibrotic human lung. Chest 1992; 102(4): 1085-1089

6 : Ramos C, Montaño M, Garcia-Alvarez J. Ruiz V. Uhal BD, Selman M and Pardo A. Fibroblasts from idiopathic pulmonary fibrosis and normal lung differ in growth rate, apoptosis, and TIMPs expression. American Journal of Respiratory Cell and Molecular Biology 2001; 24(5) 591-598 7. Uhal BD, Joshi I, Hughes WF, Ramos C, Pardo A, and Selman M. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am. J. Physiol. 275 (Lung Cell. Mol. Physiol. 19) 1998: L1192-L1199 8. Wang R, Ramos C, Joshi I, Zagariya A, Pardo A, Selman M, and Uhal BD. Human lung myofibroblast-derived inducer of alveolar epithelial apoptosis identified as angiotensin peptides. Am. J. Physiol. 1999; 277 (6) (Lung Cell. Mol. Physiol. 21): L1158-L1164 9. Selman M, Lin HM, Montaño M, Jenkins AL, Estrada A, Lin Z, Wang G, DiAngelo SL, Guo X, Umstead TM, Lang CM, Pardo A, Phelps DS, Floros J. Surfactant protein A and B genetic variants predispone to idiopathic pulmonary fibrosis. Hum. Genet. 2003 Nov; 113 (6):542-50